Augmentation strategies for treatment resistant major depression: a systematic review and network meta-analysis
Objective To compare the efficacy and discontinuation of augmentation agents in adult
patients with treatment-resistant depression (TRD). We conducted a systematic review and …
patients with treatment-resistant depression (TRD). We conducted a systematic review and …
[HTML][HTML] What is new in Rome IV
MJ Schmulson, DA Drossman - Journal of neurogastroenterology …, 2017 - ncbi.nlm.nih.gov
Functional gastrointestinal disorders (FGIDs) are diagnosed and classified using the Rome
criteria; the criteria may change over time as new scientific data emerge. The Rome IV was …
criteria; the criteria may change over time as new scientific data emerge. The Rome IV was …
Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial
DM Blumberger, F Vila-Rodriguez, KE Thorpe, K Feffer… - The Lancet, 2018 - thelancet.com
Background Treatment-resistant major depressive disorder is common; repetitive
transcranial magnetic stimulation (rTMS) by use of high-frequency (10 Hz) left-side …
transcranial magnetic stimulation (rTMS) by use of high-frequency (10 Hz) left-side …
Structural basis of ketamine action on human NMDA receptors
Y Zhang, F Ye, T Zhang, S Lv, L Zhou, D Du, H Lin… - Nature, 2021 - nature.com
Ketamine is a non-competitive channel blocker of N-methyl-d-aspartate (NMDA) receptors. A
single sub-anaesthetic dose of ketamine produces rapid (within hours) and long-lasting …
single sub-anaesthetic dose of ketamine produces rapid (within hours) and long-lasting …
[HTML][HTML] Antidepressant augmentation versus switch in treatment-resistant geriatric depression
EJ Lenze, BH Mulsant, SP Roose… - … England Journal of …, 2023 - Mass Medical Soc
Background The benefits and risks of augmenting or switching antidepressants in older
adults with treatment-resistant depression have not been extensively studied. Methods We …
adults with treatment-resistant depression have not been extensively studied. Methods We …
[HTML][HTML] The identification, assessment and management of difficult-to-treat depression: an international consensus statement
RH McAllister-Williams, C Arango, P Blier… - Journal of Affective …, 2020 - Elsevier
Background Many depressed patients are not able to achieve or sustain symptom remission
despite serial treatment trials–often termed “treatment resistant depression”. A broader …
despite serial treatment trials–often termed “treatment resistant depression”. A broader …
Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial
JW Murrough, DV Iosifescu, LC Chang… - American Journal of …, 2013 - Am Psychiatric Assoc
Objective Ketamine, a glutamate N-methyl-d-aspartate (NMDA) receptor antagonist, has
shown rapid antidepressant effects, but small study groups and inadequate control …
shown rapid antidepressant effects, but small study groups and inadequate control …
Neuromodulators for functional gastrointestinal disorders (disorders of gut− brain interaction): a Rome foundation working team report
DA Drossman, J Tack, AC Ford, E Szigethy… - Gastroenterology, 2018 - Elsevier
Background & Aims Central neuromodulators (antidepressants, antipsychotics, and other
central nervous system− targeted medications) are increasingly used for treatment of …
central nervous system− targeted medications) are increasingly used for treatment of …
[图书][B] Sleisenger and Fordtran's gastrointestinal and liver disease E-book: pathophysiology, diagnosis, management
M Feldman, LS Friedman, LJ Brandt - 2020 - books.google.com
For nearly 50 years, Sleisenger & Fordtran's Gastrointestinal and Liver Disease has been
the go-to reference for gastroenterology and hepatology residents, fellows, physicians, and …
the go-to reference for gastroenterology and hepatology residents, fellows, physicians, and …
Nonpharmacologic and pharmacologic treatments of adults in the acute phase of major depressive disorder: a living clinical guideline from the American College of …
A Qaseem, DK Owens… - Annals of internal …, 2023 - acpjournals.org
An update is available for this article. Description: The purpose of this guideline from the
American College of Physicians (ACP) is to present updated clinical recommendations on …
American College of Physicians (ACP) is to present updated clinical recommendations on …